Company news
Tron Group Inc. (OTC:TGRP) news
Tron Group Inc. news releases on 6ix. Latest, Apr 23, 2026: AACR 2025 Abstract PS5-07-23
Press releases & updates
AACR 2025 Abstract PS5-07-23
April 22, 2026
Alchem Announces Poster Presentation on its AD=229 Program at Society for Neuroscience 2025 Conference
December 2, 2025
Dr. Aman Chauhan Presents Phase 1 Study on Neuroendocrine Tumors at ESMO 2025
October 19, 2025
ESMO Abstract “1709MO - Multi-center NCI-sponsored phase I study of triapine in combination with 177Lu-dotatate in patients with well-differentiated gastroenteropancreatic neuroendocrine tumours (GEP-NETs)”
October 12, 2025
Nanopharmaceutics Announces Presentation of National Cancer Institute sponsored Phase I Study with Triapine at ESMO 2025
September 9, 2025
Nanopharmaceutics Announces End of Patient Recruitment for NCI Phase II Study with Triapine for Neuroendocrine Tumors
July 17, 2025
Nanopharmaceutics Inc. Announces Initiation of Clinical Study of Triapine + Radiation for Glioblastoma or Astrocytoma
March 31, 2025
TRON Group Inc. Announces Results of 2025 Annual Meeting of Shareholders
March 31, 2025
PRX-3140, a 5-HT4 Agonist and Sigma-1 Agonist/Antag., Modulates Glucocorticoid Insulin Suppression and Cortisol Levels
December 11, 2024
Nanopharmaceutics Announces Initiation of Clinical Study of Oral Tetrathiomolybdate Capsules in Breast Cancer Patients
October 10, 2024
Nanopharmaceutics, Inc. (TGRP) Changes Corporate Name back to TRON Group, Inc. and forms wholly-owned Nanopharmaceutics Subsidiary
June 5, 2024
Nanopharmaceutics and Northwestern University Announce Initiation of Phase I Adaptive Dose Escalation Clinical Study with Dose Expansion of Oral Triapine® in Combination with Temozolomide (TMZ) for Pa
May 13, 2024
PrecisionLife announces strategic CNS drug development collaboration with Nanopharmaceutics
June 14, 2023
Nanopharmaceutics, Inc. Announces the End of Patient Recruitment for the National Cancer Institute (NCI) Sponsored Phase 3 Clinical Study in Advanced-Stage Cervical and Vaginal Cancers with Triapine
November 1, 2022
TRON Group, Inc. and Nanopharmaceutics, Inc. Announce Definitive Merger Agreement
August 11, 2022
TRON Group Announces Entertainment Rights Acquisition
August 22, 2021
TRON Group Announces Partnership with Legend 3D for Visual Effects Services and Education
August 16, 2021
TRON Group Inc. Acquires Digital Engineering Corporation ("DEC") to be Cornerstone of R&D Division and to Manage Technology Portfolio
July 7, 2021
TRON Group Inc. Acquires American Crypto Systems, Inc in Expansion into U.S. Crypto Markets
July 5, 2021
OTC Markets Group Welcomes Newly Verified OTCQB Companies – July 19
July 19, 2016